Christopher Koh
Impact in
- Hepatology top 1%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Epidemiology top 1%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Hepatology 28
- Liver Disease and Transplantation 14
- Hepatitis C virus research 12
- Epidemiology 51
- Hepatitis B Virus Studies 42
- Liver Disease Diagnosis and Treatment 9
- Co-authors
- Theo Heller (110 shared papers)David Erwin Kleiner (64 shared papers)Yaron Rotman (12 shared papers)T. Jake Liang (19 shared papers)Jake T. Liang (2 shared papers)Jay H. Hoofnagle (19 shared papers)Joseph M. Zmuda (1 shared paper)Jeffrey S. Glenn (18 shared papers)
- Journals
- Hepatology (20 papers)Gastroenterology (12 papers)Alimentary Pharmacology & Therapeutics (11 papers)Journal of Hepatology (9 papers)Hepatology Communications (7 papers)
- Partner nations
- United StatesCanadaTürkiye
In The Last Decade
Christopher Koh
150 papers receiving 5.4k citations
Christopher Koh's Hit Papers
Peers
Comparison fields: 5 of 92
- Hepatology 680
- Epidemiology 1.8k
- Immunology 631
- Pharmacology 140
- Drug Discovery 1
Countries citing papers authored by Christopher Koh
This map shows the geographic impact of Christopher Koh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Koh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Koh more than expected).
Fields of papers citing papers by Christopher Koh
This network shows the impact of papers produced by Christopher Koh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Koh. The network helps show where Christopher Koh may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Koh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 158 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4 Hit paper breakdown → | 2014 | 709 |
| 2 | 2010 | 413 | |
| 3 | 2011 | 262 | |
| 4 | 2018 | 262 | |
| 5 | 2009 | 230 | |
| 6 | 2015 | 210 | |
| 7 | 2016 | 194 | |
| 8 | 2015 | 142 | |
| 9 | 2020 | 133 | |
| 10 | 2017 | 120 | |
| 11 | 2018 | 96 | |
| 12 | 2014 | 94 | |
| 13 | 2017 | 86 | |
| 14 | 2010 | 84 | |
| 15 | 2018 | 84 | |
| 16 | 2020 | 82 | |
| 17 | 2020 | 69 | |
| 18 | 2014 | 58 | |
| 19 | 2017 | 58 | |
| 20 | 2018 | 56 |
About Christopher Koh
Christopher Koh is a scholar working on Hepatology, Epidemiology, Pharmacology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 158 papers that have together received 5.5k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (42 papers), Liver Disease and Transplantation (14 papers), Hepatitis C virus research (12 papers), Liver Disease Diagnosis and Treatment (9 papers), Drug-Induced Hepatotoxicity and Protection (8 papers), Gastric Cancer Management and Outcomes (6 papers), Immunodeficiency and Autoimmune Disorders (5 papers) and Genetic factors in colorectal cancer (4 papers). The work is most often cited by research in Hepatology (680 citations), Epidemiology (1.8k citations), Immunology (631 citations), Pharmacology (140 citations) and Drug Discovery (1 citation). Christopher Koh has collaborated with scholars based in United States, Canada and Türkiye. Frequent co-authors include Theo Heller, David Erwin Kleiner, Yaron Rotman, T. Jake Liang, Jake T. Liang, Jay H. Hoofnagle, Joseph M. Zmuda, Jeffrey S. Glenn, Pallavi Surana and Ben L. Da. Their work appears in journals such as Hepatology, Gastroenterology, Alimentary Pharmacology & Therapeutics, Journal of Hepatology and Hepatology Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.